70 citations,
February 2021 in “International Journal of Molecular Sciences” Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.
4 citations,
September 2021 in “Biomolecules” Using Platelet-Rich Plasma and Adipose-Derived Mesenchymal Stem Cells together can improve healing, including wound healing, bone regeneration, and hair growth.
3 citations,
August 2022 in “International Journal of Molecular Sciences” The document reviews the increased incidence of hair loss (HL) and telogen effluvium (TE) in COVID-19 patients, attributing it to psychological stress, systemic inflammation, and oxidative stress. Observational studies from various countries show a higher prevalence and severity of pattern hair loss (PHL) in COVID-19 patients, with one study reporting 79% of men and 42% of women experiencing significant PHL. TE was also common, with 31.3% of patients affected. The article suggests regenerative strategies like Platelet-Rich Plasma (PRP) and Adipose-Derived Mesenchymal Stem Cells (AD-MSCs) as potential treatments, but emphasizes the need for more controlled trials to confirm their efficacy.
December 2023 in “Linköping University medical dissertations” Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.
February 2024 in “World journal of stem cells” Adipose-derived stem cells can help repair and improve eye tissues and appearance.